Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Soliris
Biotech
Roche matches AstraZeneca's rare disease blockbuster in phase 3
Roche's subcutaneous contender matched AstraZeneca’s blockbuster incumbent Soliris in phase 3, positioning it to file for approvals around the world.
Nick Paul Taylor
Feb 7, 2023 6:10am
Novartis touts new budding disease med as it battles AstraZeneca
Dec 13, 2022 10:00am
Novartis takes another swipe at AstraZeneca's rare disease gems
Dec 8, 2022 10:28am
AstraZeneca's danicopan improves hemoglobin levels in phase 3
Sep 16, 2022 9:40am
CANbridge posts early-phase data on rival to AstraZeneca drug
Feb 7, 2022 8:35am
Novartis posts Soliris rival data, aims to be standard of care
Aug 31, 2020 8:15am
